Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 692.00 | 779.25 | 0.8880 | 0.7552 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 625.00 | 414.82 | 690.00 | 779.25 | 0.8855 | 0.7497 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 625.00 | 414.82 | 933.00 | 779.25 | 1.1973 | 1.4378 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 625.00 | 414.82 | 1008.00 | 779.25 | 1.2936 | 1.6541 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 625.00 | 414.82 | 903.00 | 779.25 | 1.1588 | 1.3518 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 625.00 | 414.82 | 438.00 | 779.25 | 0.5621 | 0.0616 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 625.00 | 414.82 | 652.00 | 779.25 | 0.8367 | 0.6440 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 822.00 | 779.25 | 1.0549 | 1.1209 | |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 625.00 | 414.82 | 300.00 | 779.25 | 0.3850 | -0.2997 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 625.00 | 414.82 | 295.00 | 779.25 | 0.3786 | -0.3125 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 915.00 | 779.25 | 1.1742 | 1.3862 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 625.00 | 414.82 | 829.00 | 779.25 | 1.0638 | 1.1408 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 550.00 | 779.25 | 0.7058 | 0.3636 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 625.00 | 414.82 | 280.00 | 779.25 | 0.3593 | -0.3509 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 839.00 | 779.25 | 1.0767 | 1.1692 | |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1901.00 | 1922.63 | 0.9888 | 0.9814 | |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1954.00 | 1922.63 | 1.0163 | 1.0269 | |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 1891.00 | 1922.63 | 0.9836 | 0.9728 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 1250.00 | 830.55 | 1912.00 | 1922.63 | 0.9945 | 0.9909 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 1250.00 | 830.55 | 2202.00 | 1922.63 | 1.1453 | 1.2371 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 1582.00 | 1922.63 | 0.8228 | 0.7025 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 830.55 | 1014.00 | 1922.63 | 0.5274 | 0.1792 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 1143.00 | 1922.63 | 0.5945 | 0.3017 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 1250.00 | 830.55 | 2178.00 | 1922.63 | 1.1328 | 1.2170 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1974.00 | 1922.63 | 1.0267 | 1.0440 |